Login / Signup

Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.

Hamzah MustakShoaib UgradarRobert GoldbergDaniel Rootman
Published in: Clinical & experimental ophthalmology (2018)
Keyphrases
  • stem cells
  • pulmonary fibrosis
  • metastatic colorectal cancer
  • combination therapy
  • replacement therapy
  • bone marrow
  • cell therapy
  • smoking cessation